TomoTherapy confirms 59 percent increase in Q3 revenue

TomoTherapy confirms 59 percent increase in Q3 revenue

Madison, Wis.TomoTherapy has confirmed what it anticipated earlier this year – that its 2007 third quarter would see record-breaking sales.
TomoTherapy, which manufactures and sells the Hi·Art radiation therapy system for the treatment of a wide variety of cancers, had revenues of $59.2 million, a 59 percent increase over the $37.2 million reported for the third quarter of 2006.
Perhaps even more telling, the value of new sales orders received during the third quarter of 2007 totaled $73 million, an 82 percent increase over the third quarter of 2006. As of Sept. 30, 2007, TomoTherapy’s revenue backlog totaled $228 million, a 10 percent increase over the backlog that existed at the end of Q2 2007.
The company reported net income was $2.6 million, or $0.05 per diluted share, compared to pro forma net income of $3.1 million, or $0.08 per diluted share, for the third quarter of 2006.
For the first nine months of 2007, TomoTherapy reported revenue of $154.1 million, a 60 percent increase from the $96.5 million for the first three quarters of 2006.
Related stories
TomoTherapy forecasts 61 percent Q3 revenue surge
TomoTherapy files to sell 8.5 million additional shares of stock
TomoTherapy sells first radiation therapy system in China